BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28393627)

  • 1. Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-α.
    Ragy MM; Kamal NN
    Neurol Res; 2017 Jul; 39(7):587-595. PubMed ID: 28393627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between inflammatory response, oxidative stress, intestinal pathological damage and intestinal flora variation in rats with type 2 diabetes mellitus.
    Li J; Zhang H; Wang G
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10162-10168. PubMed ID: 33090424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients.
    Chehaibi K; Trabelsi I; Mahdouani K; Slimane MN
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2585-2593. PubMed ID: 27474112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment.
    Gorska-Ciebiada M; Saryusz-Wolska M; Borkowska A; Ciebiada M; Loba J
    PLoS One; 2015; 10(3):e0120433. PubMed ID: 25793613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative markers in diabetic ketoacidosis.
    Vantyghem MC; Balduyck M; Zerimech F; Martin A; Douillard C; Bans S; Degand PM; Lefebvre J
    J Endocrinol Invest; 2000 Dec; 23(11):732-6. PubMed ID: 11194706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes.
    Vehkala L; Ukkola O; Kesäniemi YA; Kähönen M; Nieminen MS; Salomaa V; Jula A; Hörkkö S
    Ann Med; 2013 Dec; 45(8):501-10. PubMed ID: 24131174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus.
    Wu JD; Xu XH; Zhu J; Ding B; Du TX; Gao G; Mao XM; Ye L; Lee KO; Ma JH
    Diabetes Technol Ther; 2011 Feb; 13(2):143-8. PubMed ID: 21284481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes.
    Aljwaid H; White DL; Collard KJ; Moody AJ; Pinkney JH
    J Diabetes Complications; 2015; 29(7):943-9. PubMed ID: 26104728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case-control study.
    Mohamed AA; Elmotaleb Hussein MA; Nabil Hanna I; Japer Nashwan AJ; Saleh M; Abdel Wahed WY; Mohamed Mansour AM; Ezz Al Arab MR; Fawzy N; Sakr Y; Shalby H; AlHussain E; Kamal Darwish M; El-Osaily H; Naguib M; Mohamed AA; Farouk Mohamed W; Hafez W
    Med Clin (Barc); 2024 May; 162(9):e33-e39. PubMed ID: 38458959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between changes in inflammatory cytokines and the combination with hypertension in patients with type 2 diabetes mellitus.
    He Q; Dong M; Pan Q; Wang X; Guo L
    Minerva Endocrinol; 2019 Sep; 44(3):252-258. PubMed ID: 29687969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between inflammatory biomarkers, cognitive function and glycemic and lipid profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
    Du Y; Zhang Q; Zhang X; Song Y; Zheng J; An Y; Lu Y
    Clin Biochem; 2023 Nov; 121-122():110683. PubMed ID: 37939987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study.
    Preciado-Puga MC; Malacara JM; Fajardo-Araujo ME; Wröbel K; Wröbel K; Kornhauser-Araujo C; Garay-Sevilla ME
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):484-90. PubMed ID: 25230243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications.
    Misra DP; Das S; Sahu PK
    Metab Syndr Relat Disord; 2012 Jun; 10(3):209-13. PubMed ID: 22316266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetes.
    Pieme CA; Tatangmo JA; Simo G; Biapa Nya PC; Ama Moor VJ; Moukette Moukette B; Tankeu Nzufo F; Njinkio Nono BL; Sobngwi E
    BMC Res Notes; 2017 Mar; 10(1):141. PubMed ID: 28356165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Lunar Phases on Foot Temperature, Oxidative Stress, and Inflammation in Type 2 Diabetic Subjects.
    Bhattacharjee K; Pramanik S; Chowdhury SD; Basu BR; Mondal LK
    Endocr Metab Immune Disord Drug Targets; 2023; 23(6):832-842. PubMed ID: 36475336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes.
    Chen L; Wei B; Li J; Liu F; Xuan D; Xie B; Zhang J
    J Periodontol; 2010 Mar; 81(3):364-71. PubMed ID: 20192862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent alteration in inflammatory biomarker gene expression and oxidative stress: how aerobic training and vitamin D improve T2DM.
    Hoseini R; Rahim HA; Ahmed JK
    BMC Complement Med Ther; 2022 Jun; 22(1):165. PubMed ID: 35733163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study.
    Phosat C; Panprathip P; Chumpathat N; Prangthip P; Chantratita N; Soonthornworasiri N; Puduang S; Kwanbunjan K
    BMC Endocr Disord; 2017 Jul; 17(1):44. PubMed ID: 28716139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.
    Lu L; Pu LJ; Xu XW; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Lu AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
    Clin Biochem; 2007 Jul; 40(11):810-6. PubMed ID: 17499233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass.
    João Cabrera E; Valezi AC; Delfino VD; Lavado EL; Barbosa DS
    Obes Surg; 2010 Jan; 20(1):42-9. PubMed ID: 19826889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.